secwatch / observer
8-K filed May 2, 2023, 7:59 PM ET ticker CVS CIK 0000064803
M&A confidence high sentiment positive materiality 0.85

CVS HEALTH Corp (CVS): debt financing — CVS closes $10.6B Oak Street Health buy, funds $5B via loan

CVS HEALTH Corp

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

CVS HEALTH Corp incurred term loan of $5.0 billion with Barclays Bank PLC at term SOFR or the base rate, plus, in each case, an applicable margin maturing April 30, 2024.

Instrument
term loan
Principal
$5.0 billion
Counterparty
Barclays Bank PLC
Rate
term SOFR or the base rate, plus, in each case, an applicable margin
Maturity
April 30, 2024
Event
incurrence
Exact text from the filing
On May 1, 2023, CVS Health Corporation, a Delaware corporation (“CVS Health”) entered into a 364-Day Term Loan Agreement (the “Term Loan Agreement”) with the lenders party thereto and Barclays Bank PLC, as administrative agent. The Term Loan Agreement provides for total term loan commitments in an aggregate principal amount of $5.0 billion.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CVS HEALTH Corp entered into Term Loan Agreement valued at $5.0 billion.

Action
entry
Agreement
credit facility
Value
$5.0 billion
Exact text from the filing
The Merger was financed in part with borrowings of $5.0 billion under the Term Loan Agreement, described above under Item 1.01 of this Current Report.
View on SEC.gov

Browse all debt financings →

CVS HEALTH Corp filing history →

Source: SEC EDGAR
accession 0000947871-23-000511
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.